Monte Rosa Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Monte Rosa Therapeutics's balance sheet done over the years? Its assets were worth $303,755,000 last year, which is less than in the previous period. 41% of Monte Rosa Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $124,505,000, which means an increase by 75% compared compared to last year.

Debt to Assets

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE): Debt to assets
2019 11094000 23.24M 209.5%
2020 49378000 98.10M 198.68%
2021 366329000 18.81M 5.14%
2022 342389000 70.97M 20.73%
2023 303755000 124.50M 40.99%

GLUE Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
128.10M54.91M346.07M41.69M5.99M
Short term investments
104.31M207.91M000
Net receivables
505K7.65M000
Inventory
0960K000
Other current assets
3.29M4.44M2.59M1.89M514K
Total current assets
236.21M275.88M348.66M43.59M9.75M
Non-current assets:
Property, Plant and Equipment
62.61M61.90M12.32M4.62M1.33M
Goodwill
00000
Intangible assets
00000
Long term investments
04.31M5.33M1.16M0
Other non-current assets
4.93M278K000
Total non-current assets
67.54M66.50M17.66M5.78M1.33M
Total assets
303.75M342.38M366.32M49.37M11.09M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
17.67M0000
Short term debt
6.32M3.12M00750K
Total current liabilities
46.59M25.56M16.63M29.27M4.29M
Non-current liabilities:
Long term debt
42.87M43.87M067.76M18.95M
Deferred tax
00000
Other non-current liabilities
2.71M1.53M2.17M00
Total non-current liabilities
77.91M45.40M2.17M68.83M18.95M
Total liabilities
124.50M70.97M18.81M98.10M23.24M
Data sourceData sourceData source